Here's Why You Should Consider Investing in IDEX Stock Now
IEX is gaining from strong data center, semiconductor, space and defense demand, acquisitions and shareholder returns.
IEX - IDEX Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$254.38
DETAILS
HIGH:
$280.00
LOW:
$214.00
MEDIAN:
$259.00
CONSENSUS:
$254.38
UPSIDE:
13.69%
Stock News
Canada Pension Plan Investment Board Makes New Investment in IDEX Corporation $IEX
Canada Pension Plan Investment Board acquired a new position in shares of IDEX Corporation (NYSE: IEX) in the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 16,700 shares of the industrial products company's stock, valued at approximately $3,790,000. A number of other hedge funds have also
Why Is Idex (IEX) Up 0.1% Since Last Earnings Report?
Idex (IEX) reported earnings 30 days ago. What's next for the stock?
Bard Associates Inc. Makes New $1.50 Million Investment in IDEX Corporation $IEX
Bard Associates Inc. acquired a new stake in shares of IDEX Corporation (NYSE: IEX) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 6,593 shares of the industrial products company's stock, valued at approximately $1,496,000. A number of other hedge funds
Idex (IEX) Upgraded to Buy: Here's Why
Idex (IEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More
With all eyes locked on this morning's CPI release and the Strait of Hormuz nearly shut down, Wall Street analysts are already repositioning across hospitality, pharma, and tech before the market even opens.
Empowered Funds LLC Boosts Stake in IDEX Corporation $IEX
Empowered Funds LLC lifted its position in shares of IDEX Corporation (NYSE: IEX) by 95.7% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,418 shares of the industrial products company's stock after buying an additional 4,116 shares during the quarter. Empowered
Are You Looking for a Top Momentum Pick? Why Idex (IEX) is a Great Choice
Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Amundi Sells 268,259 Shares of IDEX Corporation $IEX
Amundi trimmed its holdings in IDEX Corporation (NYSE: IEX) by 18.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,219,400 shares of the industrial products company's stock after selling 268,259 shares during the quarter. Amundi owned about
IDEX (NYSE:IEX) Sets New 52-Week High After Strong Earnings
IDEX Corporation (NYSE: IEX - Get Free Report)'s stock price reached a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $232.55 and last traded at $239.8090, with a volume of 608 shares. The stock had previously closed at $224.65. The industrial products company reported
IDEX Q2 Earnings Call Highlights
IDEX NYSE: IEX reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.
IDEX Corporation (IEX) Q2 2026 Earnings Call Transcript
IDEX Corporation (IEX) Q2 2026 Earnings Call Transcript
IDEX Beats Q2 Earnings Estimates on HST Momentum, Raises View
IEX tops second-quarter estimates, posts record orders above $1 billion and raises its 2026 outlook as demand improved across key end markets.
Compared to Estimates, Idex (IEX) Q2 Earnings: A Look at Key Metrics
The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Idex (IEX) Q2 Earnings and Revenues Top Estimates
Idex (IEX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $2.07 per share a year ago.
IDEX Reports Second Quarter Results
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2026. “We are very pleased to see continued results momentum as our IDEX teams drove another quarter of strong sales and earnings growth. Orders of over $1 billion in the quarter were a record as we continue to see elevated demand across the advantaged markets where we've focused our investments and capabilities,” said Eric D. Ashleman, IDEX Corporation.
IDEX Gears Up to Report Q2 Earnings: What's in the Cards?
IEX reports Q2 results on July 29, with revenue growth expected as Health & Science demand and acquisitions support sales despite cost pressures.
Analysts Set IDEX Corporation (NYSE:IEX) PT at $244.00
Shares of IDEX Corporation (NYSE: IEX - Get Free Report) have earned an average rating of "Moderate Buy" from the nine ratings firms that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1
Idex (IEX) Earnings Expected to Grow: Should You Buy?
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IDEX Corporation $IEX Shares Sold by California Public Employees Retirement System
California Public Employees Retirement System cut its holdings in shares of IDEX Corporation (NYSE: IEX) by 6.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 154,528 shares of the industrial products company's stock after selling 11,067 shares during the quarter.
Price Targets
Idex Corp. upgraded to Outperform from Neutral at Mizuho
$280.00
(was $237.31)
Brett Linzey
·
Mizuho Securities
Idex Corp. price target raised to $240 from $230 at DA Davidson
$240.00
(was $234.88)
D.A. Davidson
Idex Corp. price target raised to $265 from $260 at Oppenheimer
$265.00
(was $236.82)
Oppenheimer
Idex Corp. price target raised to $268 from $257 at Stifel
$268.00
(was $229.52)
Nathan Jones
·
Stifel Nicolaus
Idex Corp. price target raised to $257 from $250 at Stifel
$257.00
(was $224.94)
Nathan Jones
·
Stifel Nicolaus
Idex Corp. price target raised to $261 from $252 at RBC Capital
$261.00
(was $227.60)
RBC Capital
Idex Corp. price target raised to $250 from $242 at Oppenheimer
$250.00
(was $207.59)
Oppenheimer
Idex Corp. price target raised to $250 from $240 at Seaport Research
$250.00
(was $215.78)
Walt Liptak
·
Seaport Global
Idex Corp. price target raised to $252 from $225 at RBC Capital
$252.00
(was $217.93)
RBC Capital
Idex Corp. price target raised to $250 from $241 at Stifel
$250.00
(was $217.68)
Stifel Nicolaus
Idex Corp. price target raised to $242 from $230 at Oppenheimer
$242.00
(was $217.34)
Oppenheimer
Idex Corp. price target raised to $257 from $247 at Baird
$257.00
(was $217.34)
Robert W. Baird
Idex Corp. price target lowered to $241 from $244 at Stifel
$241.00
(was $205.12)
Stifel Nicolaus
Idex Corp. initiated with a Market Perform at BMO Capital
$214.00
(was $189.73)
BMO Capital
Idex Corp. price target raised to $240 from $197 at Seaport Research
$240.00
(was $212.25)
Seaport Global
Idex Corp. upgraded to Buy from Hold at Argus
$240.00
(was $212.94)
Argus Research
Idex Corp. price target raised to $244 from $211 at RBC Capital
$244.00
(was $211.03)
RBC Capital
Idex Corp. price target raised to $230 from $210 at Oppenheimer
$230.00
(was $209.86)
Bryan Blair
·
Oppenheimer
Idex Corp. price target raised to $247 from $210 at Baird
$247.00
(was $212.25)
Michael Halloran
·
Robert W. Baird
Idex Corp. price target raised to $220 from $200 at Stifel
$220.00
(was $196.43)
Stifel Nicolaus